From Our Leadership
As we fulfil our mission of serving patients with severe and life-threatening rare diseases, Alexion has built its European presence to meet the needs of patients locally. Today, our European operations serve patients in more than 30 countries. In addition, several of Alexion’s key global functions are based in Europe, including our EMEA headquarters in Switzerland and our global supply chain and quality operations in Ireland. We also have a global government affairs team in Brussels, a new research and development centre in Paris, and country operations throughout the region. Alexion’s talented and driven employees are dedicated to providing life-transforming treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. We invite you to learn more about what we do.